HALOZYME THERAPEUTICS, INC.

Biological Products, (No Diagnostic Substances) | SIC: 2836
Phone: (858) 794-8889
 
CIK: 0001159036
EIN: 880488686
State Location: CA
State of Inc.: DE
 
Tickers:
  • Nasdaq:HALO

Form: 10-K

Filing Date: 17 Feb 2026
Report Date: 31 Dec 2025
Accepted: 17 Feb 2026 07:08 p.m.
Accession Number: 0001159036-26-000024
 
Act: 34
File Number: 001-32335
Film Number: 26641085

Documents

Primary Document: 10-K
Accepted: 17 Feb 2026 07:08 p.m.
0001159036-26-000024-index-headers.html
Last Modified: 17 Feb 2026 02:08 p.m.
0001159036-26-000024-index.html
Last Modified: 17 Feb 2026 02:08 p.m.
0001159036-26-000024.txt
Last Modified: 17 Feb 2026 02:08 p.m.
0001159036-26-000024-xbrl.zip
Last Modified: 17 Feb 2026 02:08 p.m.
ex1036halozyme-transitiona.htm
Last Modified: 17 Feb 2026 02:08 p.m.
ex1037ceopsuagreementabsol.htm
Last Modified: 17 Feb 2026 02:08 p.m.
ex107halozyme-amendmentno3.htm
Last Modified: 17 Feb 2026 02:08 p.m.
ex191insidertradingpolicy_.htm
Last Modified: 17 Feb 2026 02:08 p.m.
ex211subsidiaries2025.htm
Last Modified: 17 Feb 2026 02:08 p.m.
ex231auditorconsent2025.htm
Last Modified: 17 Feb 2026 02:08 p.m.
ex31110qq42025.htm
Last Modified: 17 Feb 2026 02:08 p.m.
ex31210qq42025.htm
Last Modified: 17 Feb 2026 02:08 p.m.
ex3210qq42025.htm
Last Modified: 17 Feb 2026 02:08 p.m.
FilingSummary.xml
Last Modified: 17 Feb 2026 02:08 p.m.
halo-20251231.xsd
Last Modified: 17 Feb 2026 02:08 p.m.
halo-20251231_cal.xml
Last Modified: 17 Feb 2026 02:08 p.m.
halo-20251231_def.xml
Last Modified: 17 Feb 2026 02:08 p.m.
halo-20251231_g1.jpg
Last Modified: 17 Feb 2026 02:08 p.m.
halo-20251231_g2.jpg
Last Modified: 17 Feb 2026 02:08 p.m.
halo-20251231_g3.jpg
Last Modified: 17 Feb 2026 02:08 p.m.
halo-20251231_g4.jpg
Last Modified: 17 Feb 2026 02:08 p.m.
halo-20251231_htm.xml
Last Modified: 17 Feb 2026 02:08 p.m.
halo-20251231_lab.xml
Last Modified: 17 Feb 2026 02:08 p.m.
halo-20251231_pre.xml
Last Modified: 17 Feb 2026 02:08 p.m.